Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A Distinct Oncofetal B-Cell Transcriptional Program Is Activated in Infant Acute Myeloid Leukemia and Reveals Novel Therapeutic Strategies

Hamid Bolouri, PhD, Benjamin K. Johnson, PhD, Rhonda E. Ries, MA, Laura Pardo, Tiffany A. Hylkema, BS, Wanding Zhou, PhD, Jenny L. Smith, MSc, MD, Amanda R. Leonti, MS, Allison Kaeding, MD, Michael R. Loken, PhD, Jason E. Farrar, MD, Soheil Meshinchi, MD PhD, Timothy Junius Triche, Jr., PhD

Blood (2019) 134 (Supplement_1): 3768.

https://doi.org/10.1182/blood-2019-123487

Published: 2019

Journal Articles

Targeting Oncogenic Polyamines in Refractory Pediatric Leukemias Using the Anti-Protozoan Drug Α-Difluoromethylornithine (DFMO) in Combination with GC7 and Aurothioglucose

Bradley Hofmann, MSc, Sunand Kannappan, Gupta Mehul, Chunfen Zhang, MD, Susan Chi, MD, Derek Hanson, MD, Ronald Anderson, MD FRCPC, Aru Narendran, MD PhD

Blood (2018) 132 (Supplement 1): 2725.

https://doi.org/10.1182/blood-2018-99-117229

Published: 2018

Journal Articles

Ornithine Decarboxylase: Novel Prognostic Marker and Target for Multiple Myeloma Therapy

Sonali Panchabhai, MBBS, Ilana Miriam Schlam, MD, Sinto Sebastian Chirackal, PhD, Rafael Fonseca, MD

Blood (2015) 126 (23): 1824.

https://doi.org/10.1182/blood.V126.23.1824.1824

Published: 2015

Journal Articles

Microrna-29b Targets PSME4 to Inhibit Proteasome Activity and Prevent the Delivery of Aggresomes to Autophagosomes for Anti-Myeloma Benefit

Sajjeev Jagannathan, MS, Nikhil Vad, PhD, Mohamed A.Y. Abdel Malek, MD, Ehsan Malek, MD, James J. Driscoll, MD PhD

Blood (2014) 124 (21): 4703.

https://doi.org/10.1182/blood.V124.21.4703.4703

Published: 2014

Journal Articles

Protein Disulfide Isomerase Regulates Sickle Erythrocyte Volume Via ET-1 Dependent Casein Kinase II Mechanism

Shirley D Valentin-Berrios, Jose R Romero, Alicia Rivera

Blood (2011) 118 (21): 2114.

https://doi.org/10.1182/blood.V118.21.2114.2114

Published: 2011

Journal Articles

Regulation of Human Sickle Erythrocyte Hydration Status by Endothelin-1 Is Mediated by Casein Kinase II.

Jose R. Romero, PhD, Corey Hoehn, Jessica Alves, Alicia Rivera, PhD

Blood (2009) 114 (22): 3020.

https://doi.org/10.1182/blood.V114.22.3020.3020

Published: 2009

Journal Articles

Amplified Expression Profiling of Platelet Transcriptome Reveals Global Activation of Arginine Metabolic Pathways in Patients with Sickle Cell Disease.

Nalini Raghavachari, PhD, Xiuli Xu, Ph.D, Jose Villagra, M.D, Greg Kato, M.D, Peter J. Munson, Ph.D, Sidney Morris, Ph.D, Mark T. Gladwin, M.D

Blood (2006) 108 (11): 1536.

https://doi.org/10.1182/blood.V108.11.1536.1536

Published: 2006

Journal Articles

Comparative Effect of the Oral Iron Chelators ICL670A and CP20 on Cell Proliferation, Apoptosis and Polyamine Metabolism in Rat and Human Liver Cell Cultures.

François Gaboriau, PhD, Karine Chantrel-Groussard, PhD, Nicole Pasdeloup, Hans Peter Nick, Pierre Brissot, Gérard Lescoat, PhD

Blood (2005) 106 (11): 4448.

https://doi.org/10.1182/blood.V106.11.4448.4448

Published: 2005

Journal Articles

Preclinical Investigations Demonstrate Effectiveness of Aplidin in Acute Leukemias and Lymphomas and Provide the Basis for Further Clinical Studies.

Debabrata Banerjee, Ph.D., Guray Saydam, M.D., Lata G. Menon, Ph.D., Giuseppe S.A. Longo, M.D., Daniel Medina, Ph.D., Roger Strair, M.D., Ph.D., Jose Jimeno, M.D., Eugenio Erba, Ph.D., Alberto Grossi, M.D., Gertjan J.. L. Kapers, M.D., Norea Martinez, Ph.D., Joseph Bertino, M.D.

Blood (2004) 104 (11): 4496.

https://doi.org/10.1182/blood.V104.11.4496.4496

Published: 2004

Journal Articles

Classification of Highly Proliferative B Cell Lymphomas Using Differential Expression of cMYT Target Genes.

S. L. Barrans, S. J.M. O’Connor, A. C. Rawstron, J. Allan, R. G. Owen, G. M. Mead, A. S. Jack

Blood (2004) 104 (11): 2030.

https://doi.org/10.1182/blood.V104.11.2030.2030

Published: 2004

Journal Articles

Overexpression of ornithine decarboxylase enhances endothelial proliferation by suppressing endostatin expression

Takahiro Nemoto, Hisae Hori, Masataka Yoshimoto, Yousuke Seyama, Shunichiro Kubota

Blood (2002) 99 (4): 1478–1481.

https://doi.org/10.1182/blood.V99.4.1478

Published: 2002

NARROW

A Distinct Oncofetal B-Cell Transcriptional Program Is Activated in Infant Acute Myeloid Leukemia and Reveals Novel Therapeutic Strategies

Targeting Oncogenic Polyamines in Refractory Pediatric Leukemias Using the Anti-Protozoan Drug Α-Difluoromethylornithine (DFMO) in Combination with GC7 and Aurothioglucose

Ornithine Decarboxylase: Novel Prognostic Marker and Target for Multiple Myeloma Therapy

Microrna-29b Targets PSME4 to Inhibit Proteasome Activity and Prevent the Delivery of Aggresomes to Autophagosomes for Anti-Myeloma Benefit

Protein Disulfide Isomerase Regulates Sickle Erythrocyte Volume Via ET-1 Dependent Casein Kinase II Mechanism

Regulation of Human Sickle Erythrocyte Hydration Status by Endothelin-1 Is Mediated by Casein Kinase II.

Amplified Expression Profiling of Platelet Transcriptome Reveals Global Activation of Arginine Metabolic Pathways in Patients with Sickle Cell Disease.

Comparative Effect of the Oral Iron Chelators ICL670A and CP20 on Cell Proliferation, Apoptosis and Polyamine Metabolism in Rat and Human Liver Cell Cultures.

Preclinical Investigations Demonstrate Effectiveness of Aplidin in Acute Leukemias and Lymphomas and Provide the Basis for Further Clinical Studies.

Classification of Highly Proliferative B Cell Lymphomas Using Differential Expression of cMYT Target Genes.

Overexpression of ornithine decarboxylase enhances endothelial proliferation by suppressing endostatin expression

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only